Growth Metrics

Bio-Techne (TECH) Revenue Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 64.24%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.82%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 19.04%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3,790.58%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn -1.51%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.51%
Dec 31, 2025 -0.39%
Sep 30, 2025 -1.00%
Jun 30, 2025 3.55%
Mar 31, 2025 4.20%
Dec 31, 2024 8.96%
Sep 30, 2024 4.52%
Jun 30, 2024 1.59%
Mar 31, 2024 3.16%
Dec 31, 2023 0.37%
Sep 30, 2023 13,746.75%
Jun 30, 2023 4.54%
Mar 31, 2023 1.30%
Dec 31, 2022 0.86%
Sep 30, 2022 -99.22%
Jun 30, 2022 11.27%
Mar 31, 2022 19.23%
Dec 31, 2021 20.08%
Sep 30, 2021 26.21%
Jun 30, 2021 47.31%
Mar 31, 2021 25.10%
Dec 31, 2020 21.26%
Sep 30, 2020 11.44%
Jun 30, 2020 -8.26%
Mar 31, 2020 5.31%
Dec 31, 2019 5.97%
Sep 30, 2019 12.44%
Jun 30, 2019 6.33%
Mar 31, 2019 12.74%
Dec 31, 2018 13.21%
Sep 30, 2018 12.69%
Jun 30, 2018 15.12%
Mar 31, 2018 13.84%
Dec 31, 2017 16.95%
Sep 30, 2017 10.75%
Jun 30, 2017 16.19%
Mar 31, 2017 9.97%
Dec 31, 2016 9.02%
Sep 30, 2016 16.19%
Jun 30, 2016 14.53%
Mar 31, 2016 14.73%
Dec 31, 2015 8.00%
Sep 30, 2015 3.60%
Jun 30, 2015 27.17%
Mar 31, 2015 19.47%
Dec 31, 2014 33.24%
Sep 30, 2014 26.62%
Jun 30, 2014 16.42%
Mar 31, 2014 17.98%
Dec 31, 2013 11.90%
Sep 30, 2013 14.19%
Jun 30, 2013 1.01%
Mar 31, 2013 -3.14%
Dec 31, 2012 0.56%
Sep 30, 2012 -3.31%
Jun 30, 2012 0.82%
Mar 31, 2012 9.64%
Dec 31, 2011 10.27%
Sep 30, 2011 14.20%
Jun 30, 2011 16.97%
Mar 31, 2011 8.53%
Dec 31, 2010 3.34%
Sep 30, 2010 2.12%